Dhan Jeevan last traded at ₹22.69 (2026-10-13). Over the past month the stock moved -5.5%, three months the stock moved +15.2%, year the stock moved -9.2%. Its closing range over 52 weeks is ₹19.53 – ₹28.90, with the latest close 21.5% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1993, Dhanvantri Jeevan Rekha Ltd provides Medical and Health-care Services.[1]
Business Overview:[1][2] DJRL runs an NABH-accredited hospital by the name of Dhanvantri Hospital and provides a varied range of patient care and super specialty services, and other diagnostic services in Meerut. It offers specialized therapy & support, diagnosis & investigation, and medical treatment & surgery.
In the latest quarter (Jun 2026), Dhan Jeevan reported sales of ₹7.80 crore (+41.6%) and net profit of ₹0.18 crore (+200.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 7.80 | 0.29 | 3.72 | 0.18 | 0.44 |
| Mar 2026 | 7.24 | 0.39 | 5.39 | 0.30 | 0.73 |
| Dec 2025 | 7.27 | 0.29 | 3.99 | 0.17 | 0.41 |
| Sep 2025 | 5.84 | -0.07 | -1.20 | -0.14 | -0.34 |
| Jun 2025 | 5.51 | 0.14 | 2.54 | 0.06 | 0.15 |
| Mar 2025 | 5.83 | 0.04 | 0.69 | 0.03 | 0.07 |
| Dec 2024 | 5.70 | 0.19 | 3.33 | 0.15 | 0.37 |
| Sep 2024 | 5.42 | 0.24 | 4.43 | 0.17 | 0.41 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +10.6% | +10.7% | +7.2% | -3.3% | +7.7% | +27.5% | +24.2% | +41.6% |
| Operating profit growth | +700.0% | -59.6% | +300.0% | -44.0% | -129.2% | +52.6% | +875.0% | +107.1% |
| Net profit growth | – | -58.3% | – | -62.5% | -182.4% | +13.3% | +900.0% | +200.0% |
| EPS growth | – | -58.0% | – | -61.5% | -182.9% | +10.8% | +942.9% | +193.3% |
| OPM % | 4.4% | 3.3% | 0.7% | 2.5% | -1.2% | 4.0% | 5.4% | 3.7% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Dhan Jeevan reported sales of ₹25.86 crore (+14.2%) and net profit of ₹0.40 crore (-21.6%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 25.86 | 0.76 | 2.94 | 0.40 | 0.98 |
| Mar 2025 | 22.65 | 0.71 | 3.13 | 0.51 | 1.24 |
| Mar 2024 | 20.46 | 0.84 | 4.11 | 0.17 | 0.41 |
| Mar 2023 | 17.68 | 0.58 | 3.28 | -0.22 | -0.54 |
| Mar 2022 | 16.77 | 1.50 | 8.94 | 0.49 | 1.20 |
| Mar 2021 | 9.78 | -0.75 | -7.67 | -1.42 | -3.46 |
| Mar 2020 | 18.21 | 0.66 | 3.62 | -0.26 | -0.63 |
| Mar 2019 | 16.84 | 1.23 | 7.30 | 0.05 | 0.12 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +22.6% | +8.1% | -46.3% | +71.5% | +5.4% | +15.7% | +10.7% | +14.2% |
| Operating profit growth | -33.5% | -46.3% | -213.6% | – | -61.3% | +44.8% | -15.5% | +7.0% |
| Net profit growth | -93.2% | -620.0% | – | – | -144.9% | – | +200.0% | -21.6% |
| EPS growth | -93.3% | -625.0% | – | – | -145.0% | – | +202.4% | -21.0% |
| OPM % | 7.3% | 3.6% | -7.7% | 8.9% | 3.3% | 4.1% | 3.1% | 2.9% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Dhan Jeevan.
Get Free AI Stock Analysis FREE →No recent news available for Dhan Jeevan.
Dhan Jeevan shares were last quoted at ₹22.69 (+0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Dhan Jeevan has a price-to-earnings (P/E) ratio of 19.96 and a price-to-book (P/B) ratio of 0.96. The industry P/E is 102.95.
The 52-week high of Dhan Jeevan is ₹35.86 and the 52-week low is ₹19.53.
The market capitalisation of Dhan Jeevan is about ₹10.23 crore.
In the latest quarter (Jun 2026), Dhan Jeevan reported sales of ₹7.80 crore (+41.6%) and net profit of ₹0.18 crore (+200.0%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Dhan Jeevan has a 3-year ROE of 4.00%, 3-year profit growth of 56.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 19.65% of Dhan Jeevan.
Dhan Jeevan belongs to the Hospital & Healthcare Services sector.
All Hospital & Healthcare Services stocks · Browse all stocks A–Z